Alzamend NeuroALZN
13F holders, Q1 2024 (March 31)13holders
1famous investor
$1.00avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Alzamend Neuro Inc. (ALZN) in their 13F filings. The largest holders were Truist Financial Corp. ($154K), Vanguard Group Inc. ($79K) and Geode Capital Management, LLC ($52K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Alzamend Neuro Inc.
- CUSIP
- 02262M407
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $26K |
| Exits | 3 | $17K |
Ownership 13 holders
| Truist Financial Corp. | 0.00% | No change | 154,327 | $154K |
| Vanguard Group Inc. | 0.00% | No change | 78,545 | $79K |
| Geode Capital Management, LLC | 0.00% | No change | 52,397 | $52K |
| BlackRock Inc. | 0.00% | No change | 39,740 | $40K |
| Virtu Financial LLC | 0.00% | New | 26,482 | $26K |
| RFG Advisory, LLC | 0.00% | No change | 16,666 | $17K |
| Renaissance Technologies | 0.00% | Add +35.3% | 13,790 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +43.1% | 4,747 | $5K |
| Harbor Investment Advisory, LLC | 0.00% | No change | 200 | $200 |
| Osaic Holdings, Inc. | 0.00% | No change | 66 | $66 |
| Wells Fargo & Company | 0.00% | Add +11.4% | 39 | $39 |
| Morgan Stanley | 0.00% | No change | 33 | $33 |
| Parallel Advisors, LLC | 0.00% | No change | 33 | $33 |
"% of holder's portfolio" is ALZN's weight in each manager's 13F, not the share of Alzamend Neuro Inc. the manager owns.